Nina-Sophie Schmidt-Hegemann et al.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 60(7), 963-970 (2018-12-16)
68Ga-prostate-specific membrane antigen PET/CT (68Ga-PSMA PET/CT) offers unprecedented accuracy for staging of primary, persistent, or recurrent prostate cancer. Thus, we hypothesized that 68Ga-PSMA PET/CT before radiotherapy significantly affects the radiotherapeutic approach in comparison to the current standard, a CT-based approach.